Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard L Parnes

Showing results (91-100 of 110) with videos related to

Pageof 11
Sort By:
Urologic Oncology|March 11, 2015
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillanceAnnerleim Walton Diaz, Nabeel Ahmad Shakir, Arvin K George, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Clinical Genitourinary Cancer|June 23, 2016
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial CarcinomaAndrea B Apolo, Fatima H Karzai, Jane B Trepel, et al.
AJR. American Journal of Roentgenology|September 20, 2023
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical ProstatectomyEnis C Yilmaz, Yue Lin, Mason J Belue, et al.
The Journal of Urology|January 10, 2004
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statementIan M Thompson, Demetrius Albanes, Joseph W Basler, et al.
European Urology Focus|December 14, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active SurveillanceJ Kellogg Parsons, Peter A Pinto, Christian P Pavlovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 11

Showing results (91-100 of 110) with videos related to

Sort By:
Pageof 11
Urologic Oncology|March 11, 2015
Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillanceAnnerleim Walton Diaz, Nabeel Ahmad Shakir, Arvin K George, et al.
Cancer Causes & Control : CCC|June 14, 2011
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control studySong Yao, Cathee Till, Alan R Kristal, et al.
Urology|March 4, 2015
Effect of finasteride on serum androstenedione and risk of prostate cancer within the prostate cancer prevention trial: differential effect on high- and low-grade diseaseAshraful Hoque, Song Yao, Cathee Till, et al.
The Prostate|June 6, 2015
Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention TrialDanyelle A Winchester, Cathee Till, Phyllis J Goodman, et al.
Clinical Genitourinary Cancer|June 23, 2016
A Phase II Clinical Trial of TRC105 (Anti-Endoglin Antibody) in Adults With Advanced/Metastatic Urothelial CarcinomaAndrea B Apolo, Fatima H Karzai, Jane B Trepel, et al.
AJR. American Journal of Roentgenology|September 20, 2023
PI-RADS Version 2.0 Versus Version 2.1: Comparison of Prostate Cancer Gleason Grade Upgrade and Downgrade Rates From MRI-Targeted Biopsy to Radical ProstatectomyEnis C Yilmaz, Yue Lin, Mason J Belue, et al.
The Journal of Urology|January 10, 2004
First International Conference on Chemoprevention of Prostate Cancer. Overview consensus statementIan M Thompson, Demetrius Albanes, Joseph W Basler, et al.
European Urology Focus|December 14, 2022
A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active SurveillanceJ Kellogg Parsons, Peter A Pinto, Christian P Pavlovich, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2008
Phase III prevention trial of fenretinide in patients with resected non-muscle-invasive bladder cancerAnita L Sabichi, Seth P Lerner, E Neely Atkinson, et al.
JAMA|October 13, 2011
Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)Eric A Klein, Ian M Thompson, Catherine M Tangen, et al.
Pageof 11